ClinicalTrials.govpublic full text
Venetoclax Combined With Azacitidine for Consolidation Therapy in AML
acute myeloid leukemia, consolidation therapy, venentoclax, high risk, hematopoietic stem cell transplant (hsct), allogenice hematopoietic stem cell transplantation, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807681
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.